NCT Number: NCT03937635
Protocol ID: EAA173
Sponsor: ECOG
Disease Site: Multiple Myeloma
Disease Category: Multiple Myeloma
Detail: Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
The National Clinical Trial (NTC) is assigned by the National Library of Medicine when a new study appears in the clinical trials database.
ex: NCT0526225 | GY026 | NRG
Any unique identifier assigned to the protocol by the sponsor.
ex: NCT0526225 | GY026 | NRG
A sponsor is an individual, institution, company or organization that takes the responsibility to initiate, manage and/or finance the clinical trial.
ex: NCT0526225 | GY026 | NRG